New global standard for clinical evaluation is on the horizon: ISO/DIS 18969

A new global standard for clinical evaluation is on the horizon: ISO/DIS 18969. The core message is straightforward: clinical evaluations should be seen as a pr...

Compact and leak-tight powerhouse

Media-separated solenoid valve VYKA from Festo is virtually leak-free

A new life science cluster formed – “We are very strong in talent”

Stockholm and Uppsala’s joint life science cluster aims to be among the best in Europe. Pontus Holm, Life Science Coordinator for Region Stockholm, says the dec...

Upcoming training: MD software process design based on IEC 62304

Together with Intertek Academy, we offer a 2-day course in Stockholm, Sweden, covering Medical device software process design based on IEC 62304. This course is...

QAdvis is now Aurevia

Two years ago, QAdvis became part of something bigger. At first, the change was mostly visible on paper — a new owner and later a new name: Aurevia. But this wa...

GSK eyes blockbuster potential – plans five new trials

GSK sees blockbuster potential in its experimental drug candidate Mo-rez. Early trial results suggest the treatment may shrink tumours in patients with advanced...

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Copenhagen (2026)

ZEISS and EDGE leverage AI to transform bioimaging in the biopharma industry

Transforming complex bioimaging data to workflows offering actionable insights for decision-making to speed up drug discovery.

Dive Into Current Metrology Trends

ZEISS INNOVATION TALKS - new video podcast series.

Breakfast meeting in Norway: Essential Insights for Life Science Leaders on AI and Patient Journeys

We are pleased to invite you to an inspiring session with Niels Buch Leander, Chief Digital Officer at PharmaRelations.

Quality management system according to EN ISO 13485:2016 – in practice

Do you work with medical devices? Understanding and implementing a robust Quality Management System (QMS) is key to regulatory success—and often a prerequisite for CE-marking.

Upcoming training: Cybersecurity standards for medical devices

This 1-day course on Cybersecurity standards for medical devices is designed to help professionals gain an understanding of the current standards within cyberse...

Medicon Village breakfast seminar: ISO 10993-1 in practice

Don't miss our breakfast seminar at Medicon Village on May 28th: ISO 10993-1 in practice - connecting biological evaluation to your technical documentation.

FDA approves Gilead’s HIV injection: “Historic day”

Gilead Sciences’ preventive HIV drug, lenacapavir, was approved on Wednesday by the U.S. Food and Drug Administration (FDA), sparking new hope for finally break...

Swedish industrial group Alfa Laval establishes pharmaceutical division

Alfa Laval is creating a new division focused on tailored solutions for the pharmaceutical industry.

Upcoming training: Introduction to ISO 15189:2022

Do you work with quality management in a medical laboratory? Don’t miss our ISO 15189:2022 online training course on May 12-13th — designed to help you understa...

100 years of Festo

The spirit of invention is deeply rooted in our corporate culture. Since our foundation, we have been setting benchmarks by developing innovative solutions that...

Custom regulatory and clinical strategy workshops

A strong regulatory and clinical strategy early on can save months of rework later.

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...

Could an overly burdensome QMS be the organization’s own doing?

Although the above statement is intentionally somewhat provocative, it does hold a degree of truth. Organizations that are generally negative toward regulations...

GLP-1 profile leaves Novo Nordisk after 36 years

Lotte Bjerre Knudsen, one of the key figures behind Novo Nordisk’s success in obesity medicines, is leaving the company after more than three decades.

First injectable cancer medicine for home use receives green light

Johnson & Johnson has announced that its blockbuster cancer medicine Darzalex (daratumumab) is set to become the first injectable cancer treatment in Europe sui...

Drug approved for condition causing extreme hunger

The U.S. Food and Drug Administration (FDA) has for the first time approved a drug for acquired hypothalamic obesity, a condition marked by rapid weight gain dr...

Korbinian Löbmann leads scientific meeting on drug formulation: High activity in the field

Korbinian Löbmann has moderated New Updates in Drug Formulation & Bioavailability several times before. Now he is once again taking on the scientific meeting. L...